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1. Introduction 
Selection of a starting material, which will somehow mimic a naturally-existing one, is one 
of the most important points and crucial elements in biomaterials development. Material 
biomimetism is one of those approaches, where restoration of an organ’s function is 
assumed to be obtained if the tissues themselves are imitated (Barrere et al., 2008). However, 
some of the biopolymers as e.g collagen can be selected from within a group of biomimetic 
materials, since they already exist, and have particular functions in the human body. 
Collagen is one of the key structural proteins found in the extracellular matrices of many 
connective tissues in mammals, making up about 25% to 35% of the whole-body protein 
content (Friess, 2000; Muyonga et al., 2004). Collagen is mostly found in fibrous tissues such 
as tendons, ligaments and skin (about one half of total body collagen), and is also abundant 
in corneas, cartilages, bones, blood vessels, the gut, and intervertebral discs (Brinckmann et 
al., 2005). It constitutes 1% to 2% of muscle tissue, and accounts for 6% of strong, tendinous 
muscle-weight. Collagen is synthesized by fibroblasts, which originate from pluripotential 
adventitial cells or reticulum cells. Up to date 29 collagen types have been identified and 
described. Over 90% of the collagen in the body is of type I and is found in bones, skins, 
tendons, vascular, ligatures, and organs. However, in the human formation of scar tissue, as 
a result of age or injury, there is an alteration in the abundance of types I and III collagen, as 
well as their proportion to one another (Cheng et al., 2011).  
Collagen is readily isolated and purified in large quantities, it has well-documented 
structural, physical, chemical and immunological properties, is biodegradable, 
biocompatible, non-cytotoxic, with an ability to support cellular growth, and can be 
processed into a variety of forms including cross-linked films, steps, sheets, beads, meshes, 
fibres, and sponges (Sinha & Trehan, 2003). Hence, collagen has already found considerable 
usage in clinical medicine over the past few years, such as injectable collagen for the 
augmentation of tissue defects, haemostasis, burn and wound dressings, hernia repair, 
bioprostetic heart valves, vascular grafts, a drug –delivery system, ocular surfaces, and 
nerve regeneration (Lee et al., 2001). However, certain properties of collagen have adversely 
influenced some of its usage: poor dimensional stability due to swelling in vivo; poor in 
vivo mechanical strength and low elasticity, the possibility of an antigenic response (Lynn et 
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al., 2004) causing tissue irritation due to residual aldehyde cross-linking agents, poor patient 
tolerance of inserts, variability in releasing kinetics, and ineffectiveness in the management 
of infected sites (Friess, 1998). In addition, there is the high-cost of pure type I collagen, 
variability in the enzymatic degradation rate when compared with hydrolytic degradation, 
variability of isolated collagen in cross-link density, fibre size, trace impurities, and side-
effects, such as bovine spongeform encephalopathy (BSF) and mineralization. The above-
mentioned disadvantages must be considered during collagen use in medical applications 
(Pannone, 2007). 
In this review collagen will be presented and compared to its degradation product, gelatine, 
taking into account their molecular and submolecular structural properties, possibilities to 
overcome common problems related to their usage as biomaterial, i.e. the solubility and 
degradation rate mechanisms, as well as their applications in combination with other types 
of (bio)polymers. 
2. Molecular and submolecular structure of collagen vs. gelatine 
2.1 Collagen 
The collagen rod-shape molecule (or tropocollagen) is a subunit of larger collagen fibril 
aggregates. The lengths of each subunit are approximately 300 nm and the diameter of the 
triple helix is ~1.5 nm. It is made up of three polypeptide ǂ-chains, each possessing the 
conformation of a left-handed, polyproline II-type (PPII) helix (Fig. 1). These three left-
handed helices are twisted together into a right-handed coiled coil, a triple-helix which 
represent a quaternary structure of collagen, being stabilized by numerous hydrogen bonds 
and intra-molecular van de Waals interactions (Brinckmann et al., 2005) as well as some 
covalent bonds (Harkness, 1966), and further associated into right-handed microfibrils (~40 
nm in diameter) and fibrils (100-200 nm in diameter), being further assembled into collagen 
fibres (He et al., 2011) with unusual strength and stability.  
The primary structure of collagen shows a strong sequence homology across genus and 
adjacent family line (Muyonga et a., 2004), thus a distinctive feature of collagen is the 
regular arrangement of amino acids in each of the three chains of collagen subunits. The 
sequence of amino acids is characterized by a repetitive unit of glycine (Gly)-proline (Pro)-X 
or Gly-X- hydroxyproline (Hyp), where Gly accounting for the 1/3 of the sequence, whilst X 
and Y may be any of various other amino acid residues. However, the X-position is 
occupied almost exclusively by Pro, whereas Hyp is found predominantly in the Y-position 
(Gorham, 1991), both constitute of about 1/6 of the total sequence. This kind of regular 
repetition and high Gly content is found in only a few other fibrous proteins, such as silk 
fibroin and elastin, but never in globular proteins. Thus the super-coil of collagen is 
stabilized by hydrogen bonds between Gly and Pro located in neighbouring chains and by 
an extensive water-network which can form hydrogen bonds between several carbonyl and 
hydroxyl peptide residues (Brinckmann et al., 2005). Furthermore, amino acids in the X- and 
Y-positions are able to participate in intermolecular stabilization, e.g. by hydrophobic 
interactions or interactions between charged residues, mostly coming from Pro and Hyp 
residues steric repulsion (Brinckmann et al., 2005). This helical part is further flanked by 
short non-helical domains (9-26 amino acids), the so called telopeptides, which play an 
important role in fibril formation and natural cross-linking. After spontaneous helix 
formation, cross-links between chains are formed within the region of the N-terminal 
telopeptides (globular tail portion of the chains), and then the telopeptides (containing the 
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cysteine (Cys) and tyrosine (Tyr) of pro-collagen) are shed leaving the rod-like ca. 3150 
amino acid containing triple helix. These collagen rods assemble together with a quarter-
stagger to form the collagen fibre and the fibres are stabilised by further cross-links. 
Type I (Fig. 2) collagen, the predominant genetic type in the collagen family being the major 
component of tendons, bones and ligaments, is a heterotrimeric copolymer composed of two 
ǂ1 (I) and one ǂ2 (I) chains, containing approximately 1050 amino acids each. This collagen 
type contains one-third of Gly, contains no tryptophan (Trp) or Cys, and is very low in Tyr 
and histidine (His) (Muyonga et al., 2004). Its molecule consist of three domains: amino-
terminal nontriple helical (N-telopeptide), central triple helical consisting of more than 300 
repeat units and represent more than 95% of polypeptide, and carboxy-terminal nontriple 
helical (C-telopeptide) (Yamauchi & Shiiba, 2008). New data show that besides the 
telopeptides, tropocollagens still contain the N- and C-terminal propeptide sequences, called 
non-collagenous domains (Brinckmann et al., 2005), which are responsible for correct chain 
alignment and triple helix formation. The propeptides are removed before fibril formation 
and regulate the fibril formation process. Tropocollagens are staggered longitudinally and 
bilaterally by inter- and intra-molecular cross-links into microfibrils (4 to 8 tropocollagens) 
and further into fibrils. This periodic arrangement is characterized by a gap of 40 nm 
between succeeding collagen molecules and by a displacement of 67 nm. The fibrils organize 
into fibres which, in turn, can form large fibre bundles, being both stabilized by 
intermolecular cross-links (Friess, 1998). 
 
 
Fig. 1. Biosynthetic route of collagen fibers (Shoulders & Raines, 2009)  
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Fig. 2. Structure of type I collagen molecule. (Yamauchi & Shiiba, 2008) and 
(http://www.kokenmpc.co.jp/english/support/tecnical/collagen/index.html). 
Collagen types I, II, III, and V (Fig. 3) are called fibril- forming collagens and have large 
sections of homologous sequences independent of species, among which first three types are 
known to be chemotactic (Chevallay & Herbage, 2000). Type II collagen, the main 
component of a nose cartilage , the outside of the ears, the knees and parts of larynx and 
trachea, is a homotrimer composed of three ǂ1 (II) chain (Shoulders and Rains, 2009), whilst 
type III collagen, present in skin and blood vessels is homotrimer, composed of three ǂ1 (III) 
chains (Gelse et al., 2003). In type IV collagen, being present in basement membrane, the 
regions with the triple-helical conformation are interrupted with large non-helical domains, 
as well as with the short non-helical peptide interruption. Types IX, XI, XII and XIV are 
fibril associated collagens with small chains, which contain some non-helical domains. Type 
VI is microfibrillar collagen and type VII is anchoring fibril collagen (Samuel et al., 1998). 
 
 
Fig. 3. Schematic presentation of main structural differences between the most abundant 
collagen types of extracellular matrix in human tissues (Belbachir et al., 2009). 
From among all the known collagen types, three-dimensional (3D) model of fibril-forming 
type II collagen was proposed for the development of synthetic collagen tissues and the 
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study of the structural and functional aspects of collagen (Chen et al., 1995) due its orderly 
arrangement of triple helix tropocollagen molecules, results in a formation of fibrils having a 
distinct periodicity. Thus this system also allows the studies of the stereochemistry of all the 
side-chain groups and specific atomic interactions, and further evaluation of its therapeutic 
effects on collagen related diseases.  
2.1.1 Antigenicity of collagen 
A chemical compound that stimulates an immune response is called an antigen, or an 
immunogen. A host’s immune response is not directed toward the entire antigen molecule, 
but rather to specific chemical groups called epitopes, or antigenic determinants on the 
molecule, which are responsible for the immunogenic properties of the antigen. Two 
important characteristic of antigens are immunogenicity (specific immune response) and 
reactivity (ability to react with specific antigen) where “complete antigen” possess both 
characteristics, whilst, “incomplete antigen” do not show immunogenicity, but is able to 
bind with antibodies (Kokare, 2008). The status of collagen as an animal-derived 
biomaterial raise concerns regarding its potential to evoke immune response. Its ability to 
interact with secreted antibodies (antigenicity) and to induce an immune response–process 
that includes synthesis of the same antibodies (immunogenicity), are connected with 
macromolecular features of a protein, uncommon to the host species, such as collagen with 
animal origin. When compared with other proteins, collagens are weakly immunogenic, due 
to evidences of its ability to interact with antibodies (Gorham, 1991). Clinical observations 
indicate that 2-4 % of the total population posses an inherent immunity (allergy) to bovine 
type collagen (Cooperman & Michaeli, 1984). 
According to Lynn (Lynn et al., 2004), antigenic determinants (epitopes, macromolecular 
features on an antigen molecule that interact with antibodies) of collagen can be classified 
into following categories (Fig. 4): 
1.  Helical- recognition by antibodies is dependent on 3D conformation (i.e., the presence 
of an intact triple helix). 
2.  Central- recognitions are located within the triple helical portion of native collagen, but 
recognition based solely on amino acid sequence and not on 3D conformation. They are 
often hidden, only interacting with antibodies when the triple helix has unwound, e.g. 
in denaturated state. 
3. Terminal- recognitions are major antigenic determinants (Lee et al., 2001), located in the 
non-helical terminal regions (telopeptides), but can be eliminated by pepsine treatment 
leading to atelocollagen (Fig. 5) (Chevallay & Herbage, 2000; Hsu et al., 1999; Kikuchi et 
al., 2004). Telopeptide cleavage results in collagen whose triple-helical conformation is 
intact, yet as both the amino and carboxyl telopeptides play important roles in cross-
linking and fibril formation, their complete removal results in an amorphous 
arrangement of collagen molecules and a consequent loss of the banded-fibril pattern in 
the reconstituted product, and significant increase in solubility (Lynn, 2004). 
The possible use of recombinant human collagen (although more expensive) could be a way 
of removing concerns of species-to-species transmissible diseases (Olsen et al., 2003). 
However, complete immunogenic purification of non-human proteins is difficult, which 
may result in immune rejection if used in implants. Impure collagen has the potential for 
xenozoonoses, a microbial transmission from the animal tissue to the human recipient 
(Canceda et al., 2003). Anyhow, although collagen extracted from animal sources may 
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present a small degree of antigenicity, it is widely considered acceptable for tissue 
engineering on humans (Friess, 1998). Furthermore, the literature has yet to find any 
significant evidence on human immunological benefits of deficient-telopeptide collagens 
(Wahl & Czernuszka, 2006). 
 
 
Fig. 4. Classes of antigenic determinants of collagen (Lynn et al., 2004). 
 
 
Fig. 5. Telopeptide removal via pepsin treatment (Lynn et al., 2004). 
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So, atelocollagen produced from type II collagen has demonstrated its potential as a drug 
carrier, especially for gene delivery (Lee et al., 2001). However, collagen type IV possesses a 
strong immunogenic character, even after pepsin treatment (Chevallay & Herbage, 2000). 
Another approach for rendering the reduction of collagen antigenicity and the immune 
reaction, has been presented, where the amino and carboxyl side groups are blocked by 
glutarladehyde cross-linking (Hardin-Young et al., 2000). However, data from studies using 
glutaraldehyde as the cross-linking agent are hard to interpret because glutaraldehyde 
treatment is also known to leave behind cytotoxic residues. It is, therefore, possible that the 
reduced antigenicity associated with glutaraldehyde cross-linking is due to nonspecific 
cytotoxicity rather than a specific effect on antigenic determinants.  
2.2 Gelatine 
Gelatine is the product of thermal denaturation or disintegration of insoluble collagen 
(Gomez-Gullien et al., 2009) with various molecular weights (MWs) and isoionic points 
(IEPs) depending on the source of collagen and the method of its manufacturing process of 
recovery from collagen.  Collagen exists in many different forms, but gelatine is only 
derived from sources rich in Type I collagen thet generally contains no Cys. Collagen used 
for gelatine manufacturing can be from different sources, among which anyhow bovine and 
porcine gelatines are more-widely used. Alternative sources of collagen for gelatine 
production have been studied in last decade, such as fish skins, bones and fins (Nagai & 
Suzuki , 2000), sea urchin (Robinson, 1997), jellyfish (Nagai et al., 2000) and bird feet from 
Encephalopat (Herpandi et al., 2011). However, the amino acid compositions are slightly 
different among all types of gelatine from different sources. Amino acids from pigskin 
gelatine and bone gelatines do not contain Cys, but fish scale and bone gelatine instead, 
which has less content of Gly in comparison with mammalian sources (Zhang et al., 2010). 
With the exception of gelatine from pigskin origin, all other gelatines do not contain aspartic 
acid (Asp) and glutamic acid (Glu).   
During the denaturation-hydrolysis process (Fig. 6), collagen triple-helix organization is 
hydrolyzed at those sites where covalent cross-links join the three peptides, which in case of 
type B gelatine produced by partial alkaline hydrolysis of collagen, leads to polydisperse 
polypeptide mixture with average MW of 40-90 kDa, instead of MW ~ 100 kDa as related to 
collagen ǂ-chains; the collagen denaturation in its passage to gelatine can be followed 
polarimetricallly by reduction of specific optical rotation [ǂ]D  of collagen (Cataldo et al., 
2008). 
As the collagen matures, the cross-links become stabilised, because ǆ-amino groups of lysine 
(Lys) become linked to arginine (Arg) by glucose molecules (Mailard reaction), forming 
extremely stable pentosidine type cross-links. During the alkaline processing, the alkali 
breaks one of the initial (pyridinoline) cross-links and as a result, on heating the collagen 
releases, mainly, denatured ǂ-chains into solution. Once the pentosidine cross-links of the 
mature animal have formed in the collagen, the main process of denaturation has to be 
thermal hydrolysis of peptide bonds, resulting in protein fragments being from below 100 
kDa to more than 700 kDa, and with IEP between 4,6 and 9. During the acid process, the 
collagen denaturation is limited to the thermal hydrolysis of peptide bonds, with a small 
amount of ǂ-chain material from acid soluble collagen in evidence. Based on this, gelatine is 
divided into two main types: Type A, which is derived from collagen of pig skin by acid 
pre-treatment with IEP of 7 - 9, and Type B, which is derived from collagen of beef hides or 
bones by liming (alkaline process) with  IEP of 4.6 - 5.4. 
www.intechopen.com
 
Biomaterials Applications for Nanomedicine 
 
24
 
Fig. 6. Two methods for gelatine extraction from tissues containing collagen (Ikada, 2002). 
Type A gelatine (dry and ash free) contains 18.5 % nitrogen, but due to the loss of amide 
groups, Type B gelatine contains only about 18% nitrogen. Amino acid analysis of gelatine 
is variable, particularly for the minor constituents, depending on the raw material and 
process used, but proximate values by weight are: Gly 21 %, Pro 12 %, Hyp 12 %, Glu 10 %, 
alanine (Ala) 9 %, Arg 8 %, Asp 6 %, Lys 4 %, serine (Ser) 4 %, leucine (Leu) 3 %, valine (Val) 
2 %, phenylalanine (Phe) 2 %, threonine (Thr) 2 %, isoleucine (Ile) 1 %, hydroxylysine (Hyl) 
1 %, methionine (Met), His < 1 % and Tyr < 0.5 %. It should be remembered that the peptide 
bond has considerable aromatic character; hence gelatine shows an absorption maximum at 
ca. 230 nm. 
Collagen is resistant to most proteases and requires special collagenases for its enzyme 
hydrolysis. Gelatine, however, is susceptible to most proteases, but they do not break 
gelatine down into peptides containing much less than 20 amino acids (Cole, 2000). 
Gelatine forms physical gels in hydrogen-bond friendly solvents above a concentration 
larger than the chain overlap concentration (~ 2 % w/v). The gelatine sol undergoes a first 
order thermo-reversible gelation transition at temperatures lower then Tg with is ~30°C, 
during which gelatine molecules undergo an association-mediated conformational 
transition from random coil to triple helix. The sol has polydisperse random coils of gelatine 
molecules  and aggregates, whereas in gel state there is propensity of triple helices stabilized 
through intermolecular hydrogen bonding, during which, three dimensional (3D) 
interconnected network connecting large fractions of the gelatine chains is formed (Mohanty 
& Bohidar, 2003, 2005). 
On cooling, gelatine chains can rewind, but not within the correct register, and small triple-
helical segments formed may further aggregate during gel formation. The lateral 
aggregation of gelatin triple helix that give rise to collagen fibrils in vivo, does not occur in 
gelatine gels (Chavez et al., 2006). Hydrogel formation, accompanied by a disorder-order 
rearrangement in which gelatine chains partially recover the triple helix collagen structure, 
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leads to forming of renaturated gelatine with amorphous main regions of randomly-coiled 
gelatine chains interconnected with domains of spatially-ordered microcrystallites, 
stabilized by hydrogen bonds between N-H of Gly and C=O from Pro. Stabilization of 
molecular conformation and inter-helix interactions are a consequence of the existence of a 
highly-ordered hydration shell with water bridges linking two groups within the same or 
different gelatine chains. Hydrogen bond formation is responsible for the increase in 
denaturation temperature of the fixed tissue; when compared to the pig-skin and bovine 
gelatines, which have ~30% Pro and Hyp, fish gelatines possess a lesser percentage of Pro 
and Hyp (~20 %), the impact of which is thermal stability and shifting by 5-10°C to lower 
gelling and melting temperatures (Farris et al., 2009) and gel strength (Herpandy et al., 
2011). 
Despite gelatine being one of the polymers recognized for millennia, questions about its 
structure and functionality are still being discussed today. The 3D network of gelatine has 
been defined by several authors using ‘’fringed micelle’’ model in which there are micro-
crystallites interconnected with amorphous regions of randomly-coiled segments, whilst 
other authors propose the existence of local regions of protein quaternary structure, self- 
limiting in size, which can be triple-helical, only partially triple-helical or also include ǃ-turn 
and ǃ-sheet motifs (Pena et al., 2010). 
2.2.1 Antigenicity of gelatine 
Due to modern manufacturing sites and the use of highly advanced, controlled 
manufacturing processes with numerous purification steps (washing, filtration), heat-
treatments including a final ultra-heat treatment (UHT)  sterilization step followed by a 
drying of the gelatine solution, gelatine with highest quality can be prepared in regard to 
physical, chemical, bacteriological and virological safety. 
During Bovine Spongiform Encephalopathy (BSE), all products of bovine origin were under 
suspicion as being possible transmitters of disease to humans. Thus several studies have 
been done to demonstrate the capability of certain steps during gelatine production to 
inactivate BSE infectivity, showing a reduction of SE infectivity for acid demineralization 
and lime-treatment of 10 and 100 times, respectively. The combined reduction has been 
found to be 1000 times. 
The classical UHT sterilization used in gelatin manufacture should also reduce any residual 
infectivity 100 times, or more probably 1000 times (Taylor et al., 1994). Washing, filtration, 
ion exchange and other chemicals or treatments used in the manufacture of gelatine would 
reduce the SE activity even further (by an assumed ratio of 100 times). 
However, it is also a known fact that gelatine is a non-immunogenic material, yet very little 
research has been done on this theme, thus most knowledge is based on early experiments 
(Hopkins & Wormall, 1933), where this gelatine property was described to be connected 
with the absence of aromatic ring. Gelatine non-antigenicity has attracted attention by 
(Starin, 1918) who, in particular, carried out an extensive investigation, using the precipitin, 
anaphylactic, complement fixation and meiostagmin reactions, and decided that the 
injection of gelatine into rabbits, guinea-pigs and dogs failed to produce antibodies by 
gelatine. This failure of gelatine to incite antibody production has been interpreted in 
several ways, but the view most commonly held suggests that the non-antigenicity, in this 
instance, is due to the absence of aromatic groupings, as gelatine is deficient in Tyr and Trp, 
and contains only a very small amount of Phe. A similar explanation for gelatin´s non-
immunogenic property was given by (Kokare, 2008), where is stated that gelatine is non-
antigenic because of the absence of aromatic radicals. 
www.intechopen.com
 
Biomaterials Applications for Nanomedicine 
 
26
3. Cross-linking of collagen vs. gelatine and their immuno response effect 
Collagen isolation by pepsin digestion involves de-polymerization of collagen by removing 
amino and carboxyl- terminal telopeptides containing the intermolecular cross-links. The 
isolated collagen thus exhibits poor thermal stability, mechanical strength and water 
resistance, due to the destruction of natural cross-links and assembly structure by neutral salt, 
acid, alkali, or proteases during the extraction process (Sisson et al., 2009). In order to increase 
their strength and  enzyme resistance,  and to maintain their stability during implantation, 
especially for long term application, collagenous matrices are usually stabilized by cross-
linking (Yannas, 1992; Tefft et al., 1997). In addition, cross-linking permits a reduction in the 
antigenicity of collagen and, in some forms, decreases its calcification (Damnik, 1996). 
 
Method Collagen Gelatine
Chemical cross-linking
Aldehydes 
e.g. glutaraldehyde (GTA) 
 
Dialdehide starch (DAS) 
Acyl azide 
 
Diphenylphosphorylazide 
(DPPA) 
Carbodiimides, e.g.1-ethyl-3-
(3 dimethylamino-
propyl)(EDC) 
Hexamethylene diisocyanate 
Ethylene glycol diglycidyl 
ether 
Polyepoxy compounds 
 
Phenolic compounds 
 
Genipin 
 
 
Citric acid derivative (CAD) 
Charulatha et al., 2003;  
Kikuchi et al., 2004; Mu et al., 
2010, Ma et al., 2003 
Mu et al., 2010 
Charulatha et al.; 2003, 
Friess; 1999, 
Khor, 1997, Roche et al.; 2001
 
Park et al.; 2002, Pieper et al.; 
1999, Kim et al., 2001,  Song 
et al., 2006 
Friess, 1999 
 
 
Friess, 1999; Khor, 1997, 
Zeeman et al., 1999 
Han et al.; 2003; Jackson et 
al., 2010 
Ko et al.; 2007; Yan et al., 
2010 
Sisson et al.; 2009, Farrist et 
al.; 2009 
 
Martucci & Ruseckaite, 2009 
 
 
 
 
Barbetta et al.; 2010,  Natu et 
al.; 2007, Chang et al.; 2007, 
Kuijpers et al.; 2000 
 
Vargas et al.; 2008 
 
 
 
Kim et al.; 2005; Zhang et al.; 
2010; Pena et al.;2010 
Yao et al.; 2005, Lien et al.; 
2010, Bigi et al., 2002; Chiono 
et al., 2008; Mi et al., 2005 
Saito et al., 2004
Enzymatic crosslinking
Transglutaminase 
 
 
Tyrosinase 
Laccasse 
Jus et al.; 2011 
 
 
Jus et al.; 2011 
Jus et al.; 2011
Bertoni et al., 2006; Fuchs et 
al., 2010, Sztuka & 
Kolodziejska, 2008 
Chen et al., 2003 
Physical crosslinking
Dehydrothermal treatment 
(DHT) 
UV irradiation 
Ǆ-radiation 
Pieper et al., 1999;  
Tangsadthakun,  et al., 2006 
Torikai & Shibata, 1999 
Labout , 1972
Dubruel et. al.; 2007 
 
Bhat & Karim, 2009 
Cataldo et al.; 2008 
Table 1. Overview over cross-linking methods for collagen vs. gelatine materials 
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Different ways of collagen (as well as gelatine) cross-linking, either chemical, enzymatic or 
physical, have been carried out and often the method is prescribed by the target application 
(see Table 1). 
Aldehydes have a long tradition as cross-linking reagents. Treatment with glutaraldehide 
(GTA), in particular,  is intensively used. Besides its good efficiency, this cross-linking 
method is fast, inexpensive and mechanical properties are enhanced (Friess, 1999). Cross-
linking reaction occurs between carboxyl groups on the Glu and amine groups of Lys, or 
Arg forming a Shiff-base as presented on Fig. 7. However, due to the polymerization of 
GTA, cross-linking is sometimes restricted to the surface of the device and a heterogeneous 
cross-linking structure can then occur (Cheung et al., 1984). Additionally, GTA is 
incorporated into the new linkage and unreacted GTA can cause local incompatibility, 
inflammation or calcification (Luyn et al., 1995), along with limited cell ingrowth 
(Jayakrishnan et al.; 1996) and cytotoxicity (Sisson et al.,  2009) even at concentrations of 3.0 
ppm after being released into the host as a result of collagen biodegradation. From other 
side, glutaraldehide-based cross-linking is the current standard procedure for the 
production of heart valves, providing the prosthesis with low incidences of thrombo-
embolism and satisfactory haemodynamic performance (Everaerts et al., 2007). 
Reconstituted collagen membranes cross-linked with 3,3′-dithiobispropionimidate (DTBP) 
and diimidoesters-dimethyl suberimidate (DMS) (Fig. 8) are shown to be more 
biocompatible than those treated with GTA (Charulatha &  Rajaram, 2001). 
Non-toxic, water soluble substances which only facilitate the reaction, without becoming 
part of the new linkage, are acyl azides  and carbodiimides. Carbodiimides, e.g. EDC, 
couple carboxyl groups of Glu or Asp with amino groups of Lys or Hyl residues, thus 
forming stable amide bonds (Fig. 9). Reaction efficacy is increased by addition of N-
hydroxysuccinimde (NHS) which prevents hydrolysis and rearrangement of the 
intermediate (Friess, 1999; Gorham, 1991; Olde Damink et al., 1996), thus causing the 
formation of a coarse structure instead of tougher microstructure, in its absence (Chang & 
Douglas, 2007). Because EDC can only couple groups within a distance of 1 nm, this 
treatment enhances intra- and interhelical linkages within or between tropocollagen 
molecules (Sung et al., 2003), without an inter-microfibrillar cross-links (Zeeman et al., 1999). 
EDC cross-linked collagens show reduced calcification, with no cytotoxicity and slow 
enzymatic degradation (Khor, 1997; Pieper et al., 1999).  
Some natural non-toxic and biodegradable molecules with favourable biocompatibility have 
been exploited as protein cross-linkers, such as D,L-glycceraldehyde (Sisson et al., 2009), 
oxidized alginate (Balakrishnan & Jayakrishnan, 2005), dialdehyde starch (DAS (Mu et al., 
2010), Fig. 10) and genipin.  
 
 
2 Collagen-NH2  + HOC COH Collagen-N
H
C
H
C
N-Collagen
 
 
Fig. 7. Crosllinking of collagen with glutaraldehyde (GTA) 
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Fig. 8. Structure of cross-links obtained by (a) DTBP, (b) DMS and (c) acyl azide treatments 
(Charulatha &  Rajaram, 2003). 
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Fig. 9. Crosllinking of collagen with EDC and NHS: (I) collagen, (II) EDC, (III) O-acylurea 
intermediate, (IV.) CO-NH bond formation, (V) N-acylurea intermediate (VI) NHS, (VII) 
NHS-activated carboxylic group in collagen and (VIII) substituted urea (Damnik et al., 
1996). 
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Fig. 10. Cross-linking of collagen with DAS involving Schiff’s base formation between ǆ-
amino groups from Lys or Hyl side-groups of collagen and aldehyde groups in DAS (Sission 
et al., 2009) 
Recently, polyphenols, such as procyanidin (He, 2011), proanthocyanidin (Kim et al., 2005;  
Han et al., 2003), caffeic and tannic acids (Zhang et al., 2010), epigallocatehin and epicatehin 
gallates (Jackson et al., 2010), and other tannins (Pena et al., 2010) have also been used for 
this purpose, additionally bringing  antioxidant activity, pharmacological activity, and 
therapeutic potential to the biomaterial due their free-radical scavenging capacities. Not 
only the antioxidant activity of polyphenols, but also their other physiological properties, 
such as anti-allergenic, anti-inflammatory, antimicrobial, cardioprotective, and anti-
thrombotic make these compounds very interesting raw materials for medical applications 
(Pena et al., 2010). It has been shown that some of them are able to stabilize collagen and 
protect the chains from collagenase degradation more effectively than glutaraldehyde and 
carbodiimides, thus extend the implanted material over a longer period, using very low 
concentration (Jackson et al., 2010). The interactions between protein and polyphenol can 
involve hydrogen bond, covalent linkage, ionic and hydrophobic bonding. The reaction 
mechanism involves an initial oxidization of phenolic structures to quinones, which can 
readily react with nucleophiles from reactive amino acid groups in protein: sulfuhydryl 
group in Cys, amino group of Lys and Arg, amide group from Asp and Glu, indole ring of 
Trp and imidazole ring from His (Zhang et al., 2010). Nevertheless, the effect of polyphenol 
on the microstructure of collagen, i.e. from triple-helixes to fibrils, remains largely unknown. 
In reaction mechanism between gelatin and tannin are involved hydrogen bonds between 
hydroxyl groups of tannin and polar groups of gelatin, and hydrophobic interactions 
between pyrrolidine ring of Pro and pentagalloyl glucose from tannin (Obreque-Slier et al., 
2010; Pena et al., 2010).  
Anti-inflammatory properties are added values during genipin-induced cross-linking, 
showing to be 10, 000 times less cytotoxic then glutaraldehide which may produce weakly 
clastogenic responces in CHO-K1 cells (Tsai et al., 2000; Sisson et al., 2009). Moreover, the 
minimal calcium content of genipin–fixed tissue was detected (Chang, 2001). Genipin is a 
natural product, being obtained from an iridoid glucoside, geniposide abundantly present 
in Genipa Americana and Gardenia jasminoides Ellis. Although the cross-linking mechanism of 
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genipin with gelatine (or collagen) is insufficiently understood, it is known that genipin 
reacts with free amino groups of proteins (Fig. 11), such as Lys, Hyl and Arg, forming dark 
blue colour, thus acting as monomeric or oligomeric bridge which results in a comparable 
mechanical strength and resistence against enzymatic degradation as the glutaraldehyde–
fixed tissues (Mi et al., 2005; Bigi, et al., 2002); the maximum cross-linking percentage when 
using genipin as a cross-linker enriched in gelatin films, is about 85% (Bigi et al., 2002). 
Touyama group (Touyama et al., 1994) proposed a mechanism for the reaction of genipin 
with a methylamine, were, reaction occurred through a nucleophilic attack of the primary 
amine on the C3 carbon of genipin, causing an opening of the dihydropiran ring. An attack 
then followed on the resulting aldehyde group by the secondary amine group. The final step 
in formation of the cross-linking material is believed to be dimerization produced by radical 
reactions, which indicate that genipin form intra- and intermolecular cross-links that have 
heterocyclic structure with primary amino group-containing proteins. During cross-linking 
reaction, genipin introduce intermicrofibrilar cross-links between adjacent collagen 
microfibrils, which affect the mechanical properties (Sung et al., 2003). The sizes of the 
interfibrilar cross-links can vary by pH variation, during cross-linking reaction, which is pH 
dependent: under basic conditions, genipin undergoes ring-opening polymerization, thus 
enlarging the spaces between fibrils, whilst under basic and neutral conditions, reaction 
with primary amines occur (Mi et al., 2005). Studies have been also have been conducted 
using material composed of genipin cross-linked gelatine and tricalcium phosphate, 
showing no inflammation and biocompatibility of such a composite (Yao et al., 2005). In 
addition, genipin cross-linking in certain polyelectrolyte multy-layer systems is shown to 
increase cell-adhesion and the spreading on polymeric films, thus improving tissue-implant 
interfaces (Hillberg et al., 2009). 
Citric acid derivative (CAD) prepared by modification of citric acid carboxylic groups with 
NHS was introduced for cross-linking of gelatine through its amino groups leading to 
amide bonds formation (Saitoa et al., 2004). 
Several components of polyepoxy family have been reported, between which ethylene 
glycol diglycidyl ether, with two epoxide functional groups located on both molecule´s 
ends, most reactive due to the high energy is associated to the considerable strains that exist 
within the three-membered ring. For these type of cross-linking agent, the opening of the 
epoxide ring happen simultaneously to the occurrence of the cross-linking reaction, which 
can occur within acidic and basic media (Vargas et al., 2008). 
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Fig. 11. Reaction between collagen and genipin proposed by (Mi, 2005). 
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Enzymatic cross-linking was introduced in an attempt to overcome some problems with 
traditional chemical approaches. The oxidative enzymes tyrosinase and laccase (Jus et al., 
2011), as well as acyltransferase-transglutaminase,  are capable of creating covalent cross-
links in proteinaceous substrates (Fig. 12). Tyrosinases and laccases are capable of 
converting low-molecular weight phenols or accessible Tyr residues of proteins into 
quinones-reacitve species capable for non-enzymatic reactions with nucleophiles, such as 
reactive amino groups of other amino acid residues, without disruption of gelatines coil to 
helix transitions because of only 0,3% of Tyr residues in gelatine and their location outside 
of the Gly-X-Y tripeptide repeat region being responsible for gelatine’s helix formation 
(Chen et al., 2003), and thus forming quiet weak gels because of the same reasons. 
Transglutaminase catalyses the cross-linking of gelatine by formation of isopeptide bonds 
between the Ǆ-carbonyl group of a Glu residue and ǆ-amino group of Lys residue, and one 
molecule of ammonia per cross-link as by-product (Chen et al., 2003; Bertoni et al., 2006; 
Crescenzi et al., 2002). Presumably transglutaminase-catalyzed cross-linking occurs in the 
tripeptide repeat region that is responsive for gelatine’s helix forming ability (Chen et al., 
2003). The acyl-transfer enzyme catalyzes transamidation reactions that lead to the 
formation of N-ǆ-(Ǆ-glutamyl)lysine cross-links in proteins (Crescenzi et al., 2002). 
 
Collagen
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O
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H
N
O
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iso-peptide bond
+ NH3
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Fig. 12. Chemical cross-linking of Glu-carboxyl and Lys (Hyl)-amino groups in collagen and 
formation of iso-peptide bond, promote by transglutaminase (Crescenzi et al., 2002). 
The treatment by UV irradiation only modifies the surface rather than the bulk of the 
collagen (Mu et al., 2010). Cross-linking of gelatine by UV–irradiation method involve pre-
modification of gelatine amino groups (from Lys and Hyl side chains) (Dubruel et al., 2007), 
commonly by metacrilyc-anhydride (Fig. 13) (Vlierberhe et al., 2009). In subsequent step, 
water-soluble gelatine-methacrylamide can be cross-linked not only by UV treatment, but, 
also by a number of suitable polymerization processes, such as redox, thermal, Ǆ-irradiation 
or e-beam curing (Van Den Bulcke et al., 2000). Prolonged exposure to UV-rays can cause 
also the denaturation of molecule, which can be minimized by performing the irradiation in 
deaerated (oxygen-poor) solutions of the gelatine derivatives (Schacht, 2004). Cross-linkage 
by electron beam and x-ray irradiation additional perform sterilization of the substrate.  
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Fig. 13. Derivatization of gelatine amino groups with metacrilycanhydride (Schacht, 2004). 
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4. Collagen vs. gelatine as biomaterials 
Collagen was first employed as a biomaterial in medical surgery in the late 19th century 
(Burke et al., 1983; Silver et al., 1997). Subsequently, it was used in many other medical 
applications, e.g. as wound dressings, hemostats or in cardiovascular, plastic or 
neurosurgery. Most commonly, collagen type I is used in medical devices (Silver et al.; 
1997). Device production is uncomplicated and is performed in water without applying high 
temperatures, resulting in a variety of matrix forms, such as coatings, fibres, films, fleeces, 
implants, injectable solutions and dispersions, membranes, meshes, powders, sheets, 
sponges, tapes and tubes. Additionally, its properties can be adapted to desired 
requirements by additional cross-linking, although shape-instability due to swelling, poor 
mechanical strength, and low elasticity in vivo, may limit its unrestricted usage. Further 
limitations are possible antigenic responses, tissue irritations and variations in release 
kinetics (Sinha & Trehan, 2003). On the other hand, gelatine was employed as biomaterials 
more recently, i.e. tissue engineering from ~ 1970s and in recent years as a cell-interactive 
coating or micro-carrier embedded in other biomaterials (Dubruel et al., 2007). A non-
exhaustive overview of the most recent publications, subdivided by application, for either 
collagen or gelatine alone or in a combination of other biopolymers is summarized in Table 
2 which clearly indicates that gelatine has a wider- application range within the field of both 
soft and hard-tissue engineering.  
 
Speciality Collagen application Gelatine application 
Cardiology heart valves (Everaerts et al., 2007; 
Taylor  et al., 2006; Cox et al., 2010; 
Tedder et al., 2010) 
heart valves– electrospun 
gelatine-chitosan- polyurethane 
(Wong et al., 2010) 
aortic valve –gelatine 
impregnated polyester graft 
(Langley et al., 1999) 
cardiac tissue engineering 
(Alperin et al., 2005) 
Dermatology soft tissue augmentation (Spira et 
al., 2004) 
skin replacement (Lee et al., 2001) 
artificial skin dermis (Harriger  et 
al., 1998) 
skin tissue engineering (Ma  et al., 
2003; Tangsadthakun  et al., 2006)
artificial skin (Choi et al., 1999; 
Lee et al., 2003) 
soft tissue adhesives (McDermott 
et al., 2004) 
Surgery hemostatic agent (Cameron, 1978; 
Browder & Litwin, 1986) 
plasma expander 
suture 
wound dressing and repair (Rao, 
1995) 
skin replacement (artificial skin) 
nerve repair and conduits 
blood vessel prostheses (Auger et 
al., 1998; McGuigan et al., 2006, 
Amiel et al., 2006)
small intestine ( Chiu et al., 2009) 
liver – chitosan/gelatine scaffold 
(Jiankang et al., 2007) 
wound dressing (Tucci & Ricotti, 
2001) 
nerve regeneration - 
chitosan/gelatin scaffolds 
(Chiono et al., 2008) 
blod vesels( Mironov et al., 2005) 
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Orthopaedic born, tendon and ligament repair
cartilage reconstruction – collagen 
(Stone, 1997), composite of collagen 
type II/chondroitin/hyaluronan   
(Jančar et al., 2007) 
articular cartilage – 
collagen/chitosan (Yan et al., 2010) 
bone substitute -
gelatine/hydroxyapatite 
(Chang et al., 2007) 
hard tissue regeneration – 
gelatine/hydroxyapatite ( Kim et 
al., 2005) 
cartilage (Lien et al., 2010) 
cartilage defects regeneration –
chitosan/ gelatine (Guo et al., 
2006), ceramic/ gelatine (Lien et 
al.; 2009)  
bone substitute – 
gelatine/tricalcium phosphate 
(Yao et al., 2005)
Ophthalmology corneal graft (Lass et al., 1986)
vitreous implants 
artificial tears (Kaufman et al., 1994)
tape and retinal reattachment 
contact lenses  
eye disease treatment (http.....) 
ocular inserts (Natu et al., 2007) 
carriers for intraocular delivery 
of cell/tissue sheets (Lai et al., 
2010) 
contact lens - chitosan/gelatine 
(Yuan & Wei, 2004) 
eye disease treatment (Lai, 2010) 
Urology dialysis membrane 
hemodialysis  (Kon et al., 2004) 
sphincter repair (Westney  et al., 
2005)
Vascular vascular graft (Yoshida et al., 1996)
Vessel replacement, electrospin 
collagen (Li, 2005 ) 
angioplasty
Others biocoatings
cell culture  
organ replacement 
skin test 
protein , drug and gene delivery  
(Mahoney & Anseth , 2007) 
vocal cord regeneration (Hahn et 
al., 2006) 
treatment of faecal incontinence 
(Kumar et al., 1998)
plasma substitutes (Kaur et al., 
2002) 
drug delivery - 
gelatine/chrodroitin sulphate 
(Kuijpers et al., 2000) 
adipose tissue engineering for 
soft tissue remodelling  (Hong et 
al., 2005) 
Table 2. Medical applications of collagen and gelatine 
Different research groups have separately evaluated collagen/gelatine-based biomaterials 
that differ in the applied collagen/gelatine type, cross-linking agents, additives (in the case 
of composites), pore size, pore geometry, and pore distribution. Beside, only a limited 
number of cell types have been included in most studies, which makes a meaningful 
understanding of how one type of (collagen/gelatine) scaffold, with its specific properties, 
can be applied as a suitable substrate for a variety of cell types, rather difficult. In addition, 
since the collagen/gelatine-based biomaterial used as scaffolds for in vivo tissue 
engineering in the form of gels, sponges and woven meshes are required disappear by 
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resorption into the body after accomplishment of tissue regeneration, different tissues needs 
may demand biodegradable scaffolds with different physical and chemical characteristics. 
4.1 Combination with other biopolymers 
Fabrication of scaffolds from single-phase biomaterial with homogeneous and reproducible 
structures presents a challenge, due their generally-poor mechanical properties, which limit 
their use. Combination with different natural or synthetic polymers in composites or by 
introducing of e.g. ceramics is one of today´s approaches for overcoming above mentioned 
limitations. 
Along with hydroxyapatite (HA), collagen is one of two major components of the bone, 
making up 89% of the organic matrix and 32% of the volumetric composition of bone 
(O´Brien, 2011). HA, being similar to bone mineral in physicochemical properties, is well 
known for its bioactivity and osteoconductivity in vitro and in vivo. Thus, gelatine/HA 
composite is a potential temporary biomaterial for hard tissue regeneratation, in view of 
combining the bioactivity and osteoconductivity of HA with the flexibility and hydrogel 
characteristics of gelatine (Chang & Douglas, 2007; Kim et al., 2004; Narbat et al., 2006;  
Wahl & Czernuszka, 2006). Both, collagen and HA devices significantly inhibited the growth 
of bacterial pathogens, being the most frequent cause of prosthesis-related infection (Carlson 
et al., 2004).  
Modification of the collagen/gelatine scaffold materials by glycosaminoglycans 
(hyaluronan and chondroitin sulphate) was introduced in order to enhance cells migration, 
adhesion, proliferation and differentiation, and to promote preservation of the differentiated 
states of the cells, as compared to collagen/gelatine alone (Jancar et al., 2007), as well as for 
control release of antibacterial agents (van Wachem et al., 2000). Hyaluronic acid is a 
component of the extracellular matrix of some tissue (cockscomb and vitreous humour) and 
possesses high capacity lubrication, water-sorption and water retention, whilst chondroitin 
sulphate is sulfated glycosaminoglycan and is important structural component of cartilage, 
which provides its resistance to compression (Baeurle et al., 2009). 
The better collagen delivery systems, having an accurate release control, can be achieved by 
adjusting the structure of the collagen matrix or adding other proteins, such as elastin or 
fibronectin (Doillon & Silver, 1986). Thus, a combination of collagen with other polymers, 
such as collagen/liposome (Kaufman et al., 1994) and collagen/silicone (Suzuki et al., 2000), 
has been proposed in order to achieve the stability of a system, and the controlled release 
profiles of incorporated compounds. 
The addition of collagen to a ceramic structure can provide many additional advantages to 
surgical applications: shape-control, spatial adaptation, increased particle and defect wall- 
adhesion, and the capability to favour clot-formation and stabilisation (Scabbia and 
Trombelli, 2004). 
cross-linked collagen/chitosan (Kim et al., 2001; Ma et al., 2003; Wang et al., 2003; 
Chalonglarp et al., 2006) as well as gelatine/chitosan (Kim et al., 2005; Chiono et al., 2008) 
matrices were presented as a promising biomaterial for tissue engineering, to be  used in 
several specific areas, such as drug delivery, wound dressings, sutures, nerve conduit, and 
matrix templates for tissue engineering. Human connective tissues do not contain chitosan, 
but it has structural similarity to glucosaminoglycan (GAG), mostly components of ECM. 
GAG attached to the core protein of proteoglycan consist of repeating disaccharide unit, 
usually includes an uronic acid component (e.g., D and L-gluconic acid) and a hexoamine 
component (e.g., N-acetyl-D-glucosamine, which, together with glucosamine build the 
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copolymer structure of chitosan and N-acetyl-D-galactosamine). Chitosan, because of it 
cationic nature, can promote cell adhesion, can act as modulator of cell morphology, 
differentiation, movements, synthesis and function.  It is reported that chitosan induces 
fibroblasts to release interleukin-8, which is involved in migration and proliferation of 
fibroblasts and vascular endothelial cells, but, also promotes surface-induced thrombosis 
and embolization, which limits its application in blood-containing biomaterials (Wang et al., 
2003). Chitosan addition enhances poor mechanical properties of gelatine and influence on 
more controllable biodegradation rate. Chitosan, with higher Degree of deacetilation (DD), 
modified with gelatine, possess more intensive cytocooplatibility, enhance cell proliferation 
and decline cell apoptosis. From the other hand, a flexible gelatine complex with a rigid 
chitosan weakens the adhesion via neutralizing cationic sites of chitosan, with suitable 
negative-charges borne by the gelatine, and as a consequence, a gelatine/chitosan product 
shows improved cell mobility, migration and multiplication (Mao et al., 2004; Yuan et al., 
2004). Thus, networks composed of gelatine and chitosan have been studied extensively due 
its excellent ability to be processed into porous scaffolds with good cytocompatibility and 
desirable cellular response (Mao et al., 2004; Wang et al., 2003). 
The advantageous properties of collagen for supporting tissue growth have been used in 
conjunction with the superior mechanical properties of synthetic biodegradable polymers 
to make hybrid tissue scaffolds for bone and cartilage. Collagen has also been used to 
improve cells´ interactions with electrospun nanofibers of poly (hydroxyl acids), such as 
poly(lactic acid), poly(glycolic acid), poly(ǆ-caprolactone), and their copolymers (Pachence 
et al., 2007). 
Novel gelatine/alginate sponge serving as an drug carrier for silver sulfadiazine and 
gentamicin sulphate, used for wound healing (Choi et al., 1999). Alginate is known as a 
hydrophilic and biocompatible polysaccharide, and is commonly used in medical 
applications, such as wound dressing, scaffolds for hepatocyte culture, and surgical and 
dental materials. It’s content in the above-mentioned sponge cause increasing in porosity, 
resulting in enhanced water uptake ability.  
4.2 Mechanism of collagen degradation 
4.2.1 In vitro degradation 
Degradation of collagen requires water and enzyme penetration, and the digestion of 
linkages. Collagen swells to a certain extent by exposure to water, but due to its special 
sterical arrangement (triple helical conformation), native collagen can only be digested 
completely by specific collagenases and pepsin-cleaving enzymes being able to cleave 
collagen in its undenatured helical regions at physiological pH and temperature 
(Harrington, 1996; Sternlicht & Werb, 2001). Included are collagenases which cleave once 
across all three chains, such as tissue collagenases, as well as collagenases making multiple 
scissions per chain, such as collagenase from Clostridium histolyticum (CHC) (Seifter et al., 
1971) whilst non-specific proteinases, such as pepsin, which can only attack the telopeptides 
or denatured helical regions of collagen (Weiss, 1976) are responsible for further 
degradation down to amino acids.  
CHC types of collagenase are only present in tissue at very low- levels and tightly- bound to 
collagen (Woessner, 1991), while tissue collagenases cleavie to all types of collagen, with no 
preference for a special collagen substrate (Welgus et al.,; 1983). Depending on the collagen 
type, about 150-200 cleaves per chain can be made (Seifter et al., 1971).  
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To date, seven forms of CHC are known (Mookhtiar et al., 1992). All seven enzymes contain 
zinc and calcium and consist of one polypeptide chain with one active site. The zinc (II) 
atom is located in the active site and is therefore essential for catalysis, whereas the calcium 
(II) atoms are required to stabilize the enzyme conformation and, consequently, the 
enzymatic activity (Bond et al., 1984). On the basis of their primary and secondary 
structures, their substrate specifities and their method of attack, CHCs can be divided into 
two classes. Class I contains ǂ-, ǃ-, Ǆ-, and ǈ-collagenase, and firstly attacks the collagen 
triple-helix near the ends. After cleavage at the C-terminal end, a cut near the N-terminus 
follows, before collagen is successively degraded into smaller fragments. Class II consists of 
ǅ-, ǆ- and Ǉ- collagenase and cleaves the tropocollagen in its centre, to producing two 
fragments. Further digestion of the bigger fragment follows (Mookhtiar et al., 1992). 
Consequently, class II CHC better resembles tissue collagenases, which cleaves collagen into 
TCA and a TCB fragment (Seifter et al., 1971; Welgus et al., 1980). 
Collagen fibrils are degraded in a non-specific manner, with no preferential cleavage site in 
the interior or at the ends of fibrils (Paige et al.; 2002). It was concluded that collagenase is 
too large to penetrate into the fibrils, so digestion can only occur at the fibrils` surface 
(Okada et al., 1992; Paige et al., 2002). Hence, the degradation rate is directly correlated to 
those substrate molecules available on the surface. If collagen forms fibres and fibre-
bundles, and the tropocollagens within becomes inaccessible, the degradation rate is 
reduced even more (Steven, 1976). 
4.2.2 In vivo degradation 
In vivo, degradation of collagen is more complex than in vitro. Collagen implants are 
infiltrated by various inflammatory cells, e.g. fibroblasts, macrophages or neutrophils, 
which cause contraction of the implant and secret collagen-degrading enzymes, activators, 
inhibitors, and regulatory molecules. Infiltration depends on properties of the implant, such 
as collagen nature, shape, porosity and degree of cross-linking, implantation site and 
individual enzyme levels (Gorham, 1991). Collagen is degraded by endopeptidases from the 
four major classes (Table 3): mettaloproteinases, serine proteases, cysteine proteases and 
aspartic proteases, although, non-enzymatic degradation mechanisms, e.g. hydrolysis, 
participate in collagen breakdown (Okada et al., 1992). Connective tissue, for example, is 
digested by the interplay between four different classes of proteinases, which are either 
stored within cells or released when required, while for degradation of the extracellular 
matrix, MMPs are mainly responsible. Cystein and aspartic proteinases (cathepsins) degrade 
connective tissue intracellularly at acidic pH (3-5) values, whereas serine and matrix 
metalloproteinases (MMP) act extracellularly at neutral pH values (Shingleton et al., 1996). 
Anyhow, cathepsins also play a major role in intracellular digestion of phagocytosed 
material, by cleaving telopeptide containing cross-links, and under certain conditions they 
can also act extracellularly by cleaving triple-helical regions, which is followed by 
denaturation of solubilised triple-helix and further degradation by proteases (such as 
gelatinases type MMP-2 and 9), due to susceptibility of individual ǂ-chains (Baley, 2000).  
MMP enzymes represent a family of structurally and functionally related zinc- and calcium-
containing endopeptidases which degrade almost all extracellular matrix and basement 
membrane proteins (Wall et al., 2002; Bailey, 2000). To date, 24 different MMPs and 4 tissue 
inhibitors of metalloproteinases (TIMP) are characterized (Yoshizaki et al., 2002). According 
to their primary structure and substrate specify, MMPs are divided into five sub-classes. 
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Five major MMPs have been identified in humans, namely fibroblast collagenase (MMP1), 
gelatinase A (MMP-2), gelatinase B (MMP-9), neutrophil collagenase (MMP-8) and 
stromelysine (MMP-3) (Netzel-Arnett et al., 1991). Besides collagenase 4MMP-8, which is 
stored in specific granules of neutrophils, and membrane-type MMPs (MT-MMP), which are 
integral membrane cell glycoproteins, all other MMPs are synthesized if required (Imai et 
al., 1998) and able to cleave native triple-helical fibrilar collagens. 
 
Enzyme class Cellular source Substrate Activator 
Matrix metalloproteinases 
 Collagenases 
 MMP-1 
 
 MMP-8 
 
 MMP-13 
(Rodent MMP-1) 
 
 Gelatinases 
 MMP-2 
 
 MMP-9 
 
 Stromelysins 
 MMP-3 
 
 
           
 MMP-10 
Cystine proteinases 
 Cathepsins 
 B,L,C,H,N and S 
 K 
 
Serine proteinases 
 Neutrophil elastase 
 Cathepsin G 
Aspartic proteases 
 Cathepsin D 
 
 
Connective tissue cells 
Monocytes/macrophages
Neutrophilis 
 
as MMP-1 
 
 
Most cell types 
 
Connective tissue cells 
Neutriphilis/monocytes 
 
Connective tissue cells 
Macrophages 
 
 
Macrophages 
 
 
Lysosomal 
 
 
 
 
Granulocytes 
 
 
Native triple helix 
 
Native triple helix 
 
as MMP-q plus 
telopeptides 
 
Native type IV 
gelatin 
 
as MMP-2 
 
 
Collagen types III,IV 
and 
IX 
Aggrecan 
 
as MMP-3 
 
 
Telopeptide 
Bone/triple helix 
plus telopeptides 
 
 
Telopeptides/triple 
helix 
 
Telopeptide 
 
Telopeptide 
 
 
MMP-3 
Plasmin 
MMP-
3/NE 
Plasmin 
MMP-2/3 
MT-MMP 
 
MMP-1/2 
MT-MMP 
Plasmin 
MMP-2/3 
 
Plasmin 
Cathepsin 
G 
 
 
as MMP-3 
 
 
Cathepsin 
D 
Low pH 
Table 3. Major collagen degrading enzymes (Bailey, 2001). 
The mechanism of collagen degradation by MMPs is not totally resolved. One of hypothesis 
is that collagen is actually unwound by MMPs (Chung et al., 2004). Collagenases bind and 
locally unwind the triple-helical structure before hydrolysing the peptide bonds. According 
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to these, MMP-1 preferentially interact with the Gly-Leu on ǂ2 (I) chain residues and with  
Gly-Ileu on ǂ1 chain and cleaves the three ǂ chains in succession, generating two triple-
helical fragments of ¾ and ¼ the molecule length, which show lower denaturation 
temperature then physiological one, and they both denaturate, producing random 
polypeptide gelatine chains (Baley, 2000), which are further degraded by gelatinases (MMP-
2 and MMP-9) and other nonspecific enzymes as schematically presented  on Fig. 14.  
 
 
Fig. 14. Dual degradation mechanism of cross-linked fibers in the collagen implant. These 
mechanism include (left) neutral collagenase cleaving the three chains of the triple-helix and 
(right) the acid cathepsins and neutral serine proteases cleaving the nonhelical terminal 
regions (telopeptides) containing the intermolecular cross-links (Bailey, 2001). 
Existence of locally unfolded states in collagen molecule has been also suggested (Escat, 
2010), according to which, folded structure of collagen cannot fit into the catalytic site, since 
collagen triple-helix has a diameter of approximately 15 Å, whiles catalytic domain of 
MMPs has a catalytic site of only 5 Å wide. Beside, scissile bond, cleaved by collagenases is 
buried in collagen structure when collagen is exposed to solvent, which make it inaccessible 
for scission. Local unfolding is collagen triple-helix property, which occur without presence 
of collagenases, but necessary for collagen degradation in collagenase presence. In addition, 
immino-poor regions in collagen are thought to carry biological information, such as cell 
recognition or protein binding sites (Brodsky & Persikov, 2005), but may play also an 
important role in collagen degradation (Fields, 1991). 
MMP expression is induced by various cytokines, e.g. interleukin-1, and growth factors 
(Shingleton et al., 1996). MMPs are secreted as latent inactive pro-enzymes (zymogens) 
which have to be activated before they have complete proteolytic activity (Overall, 1991). 
Four amino acids (three His and one Cys) are coordinated to the zinc atom in the active 
centre of zymogens (Birkedal-Hansen et al., 1993), being proposed by a “cysteine switch 
model”. The linkage to the Cys residue is thought to be cleaved and a water molecule, 
which must be the fourth substituent in the active enzyme can bind (Nagase et al., 1999). In 
vivo, zymogens are activated by removal of a pro-peptide by proteinases, like plasmin or 
stromelysin, followed by a second activation step provoked by proteinases or autocatalysis 
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(Shingleton et al., 1996). Additionally, activation is controlled by TIMPs, which can prevent 
activation of zymogens and/or action of activated MMPs. In vitro, trypsin and 
organomercurials can be used for activation as well (Overall, 1991). Physical agents unfold 
the structure, the zinc-cysteine contact breaks and the propeptide is cleaved auto-
catalytically (Woessner, 1991). 
Tissue collagenases cleave tropocollagen at one single site, producing TCA and TCB 
fragments about three-quarters and one-quarter of the original molecule size. After this 
initial cleavage, the helical fragments spontaneously denature at body temperature and are 
subsequently further digested by other proteinases (Mallya et al., 1992). This secondary 
degradation can take place extracellularly or intracellularly after phagocytosis (Harris, et al., 
1974). Apart from collagenases, gelatinases play an important role in collagen degradation. 
Besides, with any further degradation of initially-cleaved collagen, gelatinases can degrade 
native collagen type I, IV, V and VII (Overall, 1991). Furthermore, levels of gelatinases are 
considered to be a good index whether inflammation is present or not, because high 
concentrations are only available when a normal remodeling process is disrupted (Trengove 
et al., 1999). 
4.2.3 Immunological response of collagen-based biomaterials 
As already mentioned, the implantation of biomaterials often initiates acute inflammatory 
responses, which sometimes can cause chronic inflammatory response. Measuring the 
intensities and duration of the immune responses against implanted biomaterials is 
important for biocompatibility evaluation. The tissue response towards implanted 
biomaterials (also called the foreign body reaction) is influenced by morphology and 
composition of the biomaterial and the place where biomaterial is implanted (Ye et al., 2010; 
Jansen et al., 2008; Wang et al., 2008). Inflammation reaction is manifested by secretion of 
large amount of antibodies (secreting B cells and T cells with cytotoxic activity) and 
cytokines, in presence of foreign materials (as scaffolds) or pathogens. The 
microenvironment of the implant further changes, so, determination of immunological 
response after in vivo implantation is based of measuring the level of pro-inflammatory 
cytokine secretions and antibody secretions, and monitoring the population changes of 
immune cells ( Song et al., 2006; Hardin-Young et al., 2000).  
According to (Luttikhuizen et al., 2007), collagen-based scaffolds are mainly infiltrated by 
Giant cells that phagocytose and degrade the collagen bundles, until the material is 
completely disposed of. This is a chronic inflammatory reaction, which last until the 
material is completely degraded, after which the cells that are involved disappear. 
As an alternative for collagens isolated from calf skin and bond, as a risk-carry materials of 
bovine spongiform encephalophaty and transmissible spongiform encephalopathy, novel 
forms of acid-soluble collagen, extracted from jellyfish was proposed (Song et al., 2006), 
because of their differences in amino acid composition: jellyfish collagen had higher content 
of Gln (glutamine) and Glu, lower Pro content, small Tyr content, comparing with bovine 
and also contains Cys, which is not common for bovine collagen.  
4.2.4 New sources of gelatine 
Currently gelatine for food and used by the pharmaceutical industry is derived almost 
exclusively from animal products. About 55,000 tons of animal-sourced gelatine is used 
each year. Recently, an advance toward turning corn plants into natural factories producing 
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high-grade gelatine in a safe and inexpensive manner has been introduced as an alternative, 
enabling the development of a variety of gelatines with specific MWs and properties 
tailored to suit various needs. Beside, plant-derived recombinant gelatine would address 
concerns about the possible presence of infectious agents in animal by-products and the lack 
of traceability of the source of the raw materials currently used to make gelatine. Resourcing 
plant materials to recover and purify recombinant gelatine has remained a challenge 
because only very low levels accumulate at the early stages of the development process. 
Furthermore, since recently, gelatines are also produced biotechnologically by the use of 
recombinant DNA technology, which opens the possibility to manipulate the amino 
acid sequence of gelatines, and thereby to functionalize them for specific purposes. The 
biotechnological production of recombinant gelatine also eliminates the risk of prion 
contaminations, which are possible, present in non-recombinant animal source gelatines ( 
Sutter et al., 2007). Thus, many commercial recombinant collagens already exist on the 
market and are becoming commonly used in the development of medical soft and hard 
tissue repair applications (Pannone, 2007).  
5. Conclusion 
This review presents the characteristic properties of both fibrous proteins including 
biocompatibility, non-immunogenicity, their capacities for  modification at the molecular 
level, thus rendering or tuning their functional (surface/interfacial, mechanical, topological 
and morphological) properties, characteristic gelation (sol-gel transition) and gel-forming 
abilities and, finally, their bio-absorbability and biodegradability. In addition, their 
expanding applications for biomaterials are compared, with emphasis on the importance of 
understanding their suitability, as defined biomaterials with specific properties, for certain 
cell types. Finally, new perspectives for further study and development indicated, providing 
satisfactory interaction and imitation of biological functions. 
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